GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $29.29 and traded as low as $28.77. GENMAB A/S/S shares last traded at $29.43, with a volume of 342,399 shares changing hands.
GENMAB A/S/S Trading Down 0.7 %
The business has a 50-day moving average of $29.30 and a 200 day moving average of $30.37.
GENMAB A/S/S Company Profile
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Featured Stories
- Five stocks we like better than GENMAB A/S/S
- How to invest in marijuana stocks in 7 steps
- Comprehensive PepsiCo Stock Analysis
- What is the S&P 500 and How It is Distinct from Other Indexes
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How to Use Stock Screeners to Find Stocks
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
